ERBB2 and breast cancer: This study aimed to investigate whether establishing a machine learning (ML) model based on contrast-enhanced cone-beam breast computed tomography (CE-CBBCT) radiomic features could predict human epidermal growth factor receptor 2-positive breast cancer (BC).